STA 4783

DRUG2 trials

Sponsors

Synta Pharmaceuticals Corp., Karolinska Institutet

Conditions

Alzheimer DementiaStage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung CancerStatins

Phase 1

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

CompletedNCT00088088

Synta Pharmaceuticals Corp.Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer

Start: 2004-03-31End: 2005-03-31Target: 86Updated: 2008-12-04

Unknown Phase

Statins, Cholesterol and Cognitive Decline in Alzheimer's

CompletedNCT06635252

Karolinska InstitutetAlzheimer Dementia, Statins

Start: 2025-01-01End: 2025-03-01Updated: 2025-05-02